Cash from Operations (TTM) Chart

View Cash from Operations (TTM) for INBP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (TTM) Chart
Start Trial

Historical Cash from Operations (TTM) Data

View and export this data back to 1999. Start Trial.
Date Value
March 31, 2026 3.026M
December 31, 2025 3.125M
September 30, 2025 2.709M
June 30, 2025 2.065M
March 31, 2025 1.288M
December 31, 2024 2.315M
September 30, 2024 0.287M
June 30, 2024 0.943M
March 31, 2024 -0.057M
December 31, 2023 -0.23M
September 30, 2023 1.553M
June 30, 2023 1.232M
March 31, 2023 5.121M
December 31, 2022 4.326M
September 30, 2022 2.982M
June 30, 2022 4.091M
March 31, 2022 2.10M
December 31, 2021 2.599M
September 30, 2021 3.233M
June 30, 2021 3.05M
March 31, 2021 0.128M
December 31, 2020 1.445M
September 30, 2020 1.572M
June 30, 2020 1.339M
March 31, 2020 4.176M
Date Value
December 31, 2019 2.30M
September 30, 2019 1.42M
June 30, 2019 0.328M
March 31, 2019 -0.474M
December 31, 2018 -0.386M
September 30, 2018 0.157M
June 30, 2018 1.168M
March 31, 2018 0.525M
December 31, 2017 0.49M
September 30, 2017 2.527M
June 30, 2017 0.397M
March 31, 2017 1.438M
December 31, 2016 1.109M
September 30, 2016 -1.556M
June 30, 2016 -0.594M
March 31, 2016 -0.974M
December 31, 2015 0.201M
September 30, 2015 0.818M
June 30, 2015 -0.113M
March 31, 2015 -0.176M
December 31, 2014 -0.593M
September 30, 2014 0.613M
June 30, 2014 1.877M
March 31, 2014 1.517M
December 31, 2013 0.541M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Medifast, Inc. 8.792M
BioForce Nanosciences Holdings, Inc. -0.0419M
Skinvisible, Inc. 0.0038M
Nevis Brands, Inc. 0.0448M
Skinhealth Systems, Inc. 21.96M